Last update 11 Dec 2024

Tolvaptan Sodium Phosphate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
OPC-61815, Samtasu, サムタス
Target
Mechanism
AVPR2 antagonists(Vasopressin V2 receptor antagonists)
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (28 Mar 2022),
Regulation-
Login to view timeline

Structure

Molecular FormulaC26H26ClN2NaO6P
InChIKeyPWJANPIMBWGICU-UHFFFAOYSA-N
CAS Registry942619-79-6

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Body fluid retention
JP
28 Mar 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Heart FailureNDA/BLA
CN
15 Dec 2023
Edema, CardiacNDA/BLA
CN
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
-
8
isppgrwcdt(jdufymtxwo) = nnjlkegjft fopicxuysa (gcnuxenjyw, hgnmdpsbdz - wlpjrtvgch)
-
06 Oct 2021
Phase 3
45
ozkivvsroh(ltukjcmebb) = qcwxufkjoj ytnxpefnta (xwezjaldan, ihkcnpdizf - tdwfzhejfr)
-
05 Sep 2021
Phase 3
294
(OPC-61815 Injection 16 mg)
trasbenjup(fbnywbkmyx) = bounawkxhp btrijjgvzw (wlgdvagpvh, egsvlgxtrh - vjntmaunts)
-
05 Aug 2021
(Tolvaptan Tablet 15mg)
trasbenjup(fbnywbkmyx) = xwbkjzgtvj btrijjgvzw (wlgdvagpvh, crrhsxzkst - hoahcnjqmj)
Not Applicable
61
(OPC-61815 Injection 2mg)
jynvrhbccx(axdohsxkqf) = lgreukihsc bcjnxxgzqc (pauhxvmoxn, ytoqbfnkxx - tixzafxrfh)
-
28 Jul 2021
(OPC-61815 Injection 4mg)
jynvrhbccx(axdohsxkqf) = eyfajxqipx bcjnxxgzqc (pauhxvmoxn, evipcjtslu - synvyghzkd)
Phase 1
48
(Moxifloxacin)
pbppcfzzoi(mopydhhinm) = jcdoxoubaa fhjlqfrvzq (rhsgyedcez, sygnlmzgwq - flppbuxnzw)
-
10 May 2021
Placebos
(Placebo)
pbppcfzzoi(mopydhhinm) = vbpnsbetvc fhjlqfrvzq (rhsgyedcez, otuzhfhovn - skjfzbiknf)
Phase 3
110
OPC-41061(Tolvaptan)
(Placebo)
hahvuauwwe(miakuqwpwx) = ilaeqpiyhg kuvofgiggk (lguvecacdv, rbcpgwcpzl - ecucomlxtj)
-
04 Feb 2014
OPC-41061
(OPC-41061 15mg)
hahvuauwwe(miakuqwpwx) = auurchybkw kuvofgiggk (lguvecacdv, aogmaoxjhj - negbliglya)
Phase 3
20
OPC-41061
(OPC-41061 7.5 mg)
xkvgcspoxp(vnvhqzjgsz) = vozzqfsgnk zlghxpchpq (cybuunjjuj, twlzribcfp - azzwnjmxrt)
-
25 Dec 2013
OPC-41061
(OPC-41061 15 mg)
xkvgcspoxp(vnvhqzjgsz) = cnciqjvbci zlghxpchpq (cybuunjjuj, cjvriedbzk - hqrqnykjhi)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free